Granules India Limited (GRANULES.NS) NSE

612.40

-2.4(-0.39%)

Updated at December 24 03:29PM

Currency In INR

Granules India Limited

Address

My Home Hub

Hyderabad, 500081

India

Phone

91 40 6904 3500

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

4057

First IPO Date

June 20, 2005

Key Executives

NameTitlePayYear Born
Chaitanya TummalaCompany Secretary & Compliance Officer7.89MN/A
Mukesh SuranaChief Financial Officer14.57M1981
Harsha ChigurupatiExecutive Director23.68M1983
Priyanka ChigurupatiHead of Marketing & Executive Director23.68MN/A
Krishna Prasad ChigurupatiChairman & MD236.84M1954
Manikandan RamalingamSenior VP and Head Formulation R&D0N/A
N. BaskaranPresident - Head API Manufacturing & Operations0N/A
V. SrinivasChief Technology Officer and Head of R&D01966
Rajesh KapoorPresident & Global Head of Quality0N/A
Atul DhavleChief Human Resources Officer01970
Krishna MohanVP & Head of IT0N/A
Ramraj RangarajaluPresident & Head of Formulations Operations0N/A
Sanjay KumarPresident and Chief Strategy & Sustainability Officer0N/A

Description

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.